Mariana Hugo Silva is a Postdoctoral Researcher at Ghent University, working closely with Pfizer to provide mechanistic insights into mRNA-LNP vaccines. She earned her PhD from the University of Limerick, Ireland, conducting research across academic and industry settings including Johnson & Johnson and Trinity College Dublin. Her doctoral work focused on developing innovative long-acting injectable formulations for small molecules, aimed at improving patient adherence through controlled drug release. With a strong foundation in formulation science and industry experience, Mariana’s current research advances understanding of large-molecule delivery systems in biopharma.